Hologic Inc
NASDAQ:HOLX

Watchlist Manager
Hologic Inc Logo
Hologic Inc
NASDAQ:HOLX
Watchlist
Price: 60.56 USD -1.34% Market Closed
Market Cap: 13.6B USD

During the last 3 months Hologic Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 17% over this period (open performance analysis).

The last transaction was made on Dec 4, 2024 by Mitchell Essex D (Chief Financial Officer) , who sold 1.9m USD worth of HOLX shares.

Last Transactions:
Mitchell Essex D
Chief Financial Officer
$-1.9m
Oberton Karleen Marie
Vice President of Global Marketing for Breast and Skeletal Health
$-4.2m
Schnittker Brandon
Vice President, Service
$-39.6k
Cohn Benjamin Jordan
Director
$-417.6k
Macmillan Stephen P
Chief Executive Officer
$-615.3k
Macmillan Stephen P
Chief Executive Officer
$-294.2k
Stamoulis Christiana
Acting Chief Financial Officer & Head of Corporate Strategy
$-718.6k
Garrett Scott T
Division President, Surgical Solutions
$-1.2m
Dockendorff Charles J
Director
$-111.6k
Crawford Sally
Director
$-690.6k
Oberton Karleen Marie
Vice President of Global Marketing for Breast and Skeletal Health
$-1.1m
Dockendorff Charles J
Director
$-1.2m
Garrett Scott T
Division President, Surgical Solutions
$-687.1k
Macmillan Stephen P
Chief Executive Officer
$-3.4m
Mitchell Essex D
Chief Financial Officer
$-538.9k
Mitchell Essex D
Chief Financial Officer
$-200.1k
Cohn Benjamin Jordan
Director
$-778.4k
Hellmann Elisabeth A
Investor Relations
$-126k
Macmillan Stephen P
Chief Executive Officer
$-1.6m
Thornal Kevin R
Chief Financial Officer (CFO)
$-499.6k
Griffin John M.
Director, Investor Relations
$-1.8m
Macmillan Stephen P
Chief Executive Officer
$-3.3m
Oberton Karleen Marie
Vice President of Global Marketing for Breast and Skeletal Health
$-1.1m
Verstreken Jan
Regional President, International
$-512.2k
Cohn Benjamin Jordan
Director
$-302.7k
Cohn Benjamin Jordan
Director
$-242.3k
Cohn Benjamin Jordan
Director
$-161.6k
Daugherty Sean S.
General Counsel and Secretary
$-155k
Cohn Benjamin Jordan
Director
$-194.8k
Cohn Benjamin Jordan
Director
$-387.4k
Griffin John M.
Director, Investor Relations
$-2m
Daugherty Sean S.
General Counsel and Secretary
$-260.1k
View All Transactions

During the last 3 months Hologic Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 17% over this period (open performance analysis).

The last transaction was made on Dec 4, 2024 by Mitchell Essex D (Chief Financial Officer) , who sold 1.9m USD worth of HOLX shares.

Sold
0-3
months
0 USD
0
3-6
months
1.9m USD
1
6-9
months
6.3m USD
5
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Hologic Inc
Insider Trading Chart

Hologic Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Hologic Inc
Last Insider Transactions

Global
Insiders Monitor

Hologic Inc
Glance View

Economic Moat
None
Market Cap
13.7B USD
Industry
Health Care

Hologic Inc., headquartered in Marlborough, Massachusetts, crafts a narrative deeply intertwined with the vital mission of women's health. Established in 1985, the company has grown into a prominent player in the medical device and diagnostics realm. Hologic’s success is anchored in its core business sectors: Breast & Skeletal Health, Diagnostic Solutions, GYN Surgical, and Medical Aesthetics. The cornerstone of this expansive operation is innovation, driving the development of advanced technologies like 3D mammography systems that revolutionize breast cancer detection. This strategic focus on high-value diagnostics and medical equipment allows Hologic to capture significant market share, ensuring a steady revenue stream from both capital equipment sales and ongoing service and maintenance contracts. Beyond its robust presence in imaging and diagnostics, Hologic amplifies its influence through a comprehensive array of solutions for early stage disease detection and treatment. Their Diagnostic Solutions arm, particularly strengthened by molecular diagnostic tests, is a response to the increasing global demand for rapid and accurate testing solutions—a need only intensified by recent global health challenges. These products not only provide critical tools for healthcare professionals but also secure recurring income for Hologic through the sale of consumables and tests. By embedding itself in the cycles of medical advancements and enhancing the standard of care, Hologic generates sustainable growth and remains a crucial ally in both public and specialized health sectors. The company’s blend of technology-driven products and strategic agility enables it to navigate dynamic markets while maintaining a resolute focus on improving health outcomes around the world.

HOLX Intrinsic Value
77.15 USD
Undervaluation 22%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top